Childhood obesity: Evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 5-6, 2011, Pages 361-367

  Mantovani, Rafael M ^a   Rios, Danyelle R A ^a   Moura, Letícia C R ^a   Oliveira, Juliana M ^a   Carvalho, Flávia F ^a   Cunha, Sarah B ^a   Viana, Maria De Fátima S ^a   Lamounier, Joel A ^a   Castro, Juni C ^a   Dusse, Luci Maria S ^a   Simões E Silva, Ana Cristina ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Apt 1104 ^*  (Brazil)

Author keywords

adipose tissue; insulin resistance; leptin; obesity; plasminogen activator inhibitor 1

Indexed keywords

BIOCHEMICAL MARKER; INSULIN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ABDOMEN; ADOLESCENT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; BODY HEIGHT; BODY MASS; CHILD; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PEDIATRICS; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PUBERTY; RISK FACTOR; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; VISCERA; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INTRA-ABDOMINAL FAT; LEPTIN; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PUBERTY; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 79959434681     PISSN: 0334018X     EISSN: 0334018X     Source Type: Journal    
DOI: 10.1515/JPEM.2011.015     Document Type: Article

References (52)

1. WHO. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Technical Report Series 894, 2000.
2. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, et al. The relation of childhood BMI to adult adiposity: the Bogalusa heart study. Pediatrics 2005;115:22-7. (Pubitemid 43046277)
3. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-73. (Pubitemid 27408568)
4. Lee WW. An overview of pediatric obesity. Pediatr Diabetes 2007;8(Suppl 9):76-87. (Pubitemid 350066651)
5. Speiser PW, Rudolf MC, Anhalt H, Camacho-Hubner C, Chiarelli F, et al. Obesity Consensus Working Group. Childhood obesity. J Clin Endocrinol Metab 2005;90:1871-87. (Pubitemid 40464063)
6. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998;97:2099-100. (Pubitemid 28262114)
7. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002;3:85-101. (Pubitemid 34827150)
8. Alessi MC, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 2007;18:240-5. (Pubitemid 46743045)
9. Caballero AE, Bousquet-Santos K, Robles-Osorio L, Montagnani V, Soodini G, et al. Overweight Latin children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care 2008;31:576-82.
10. Valle Jiménez M, Estepa RM, Camacho RM, Estrada RC, Luna FG, et al. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 2007;156:497-502. (Pubitemid 46672652)
11. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, et al. Correlation between blood fibrinolytic activity, plasmino-gen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 1986;35:250-3. (Pubitemid 16137633)
12. Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 2000;49:890-5. (Pubitemid 30483443)
13. Umpaichitra V, Hussain MM, Castells S. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity. Pediatr Res 2005;58:483-7. (Pubitemid 41254511)
14. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, et al. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996;16:368-74. (Pubitemid 26084311)
15. Ferguson MA, Gutin B, Owens S, Litaker M, Tracy RP, et al. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 1998;67:1136-40. (Pubitemid 28259499)
16. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, et al. Visceral fat as a main determinant of plasmino-gen activator inhibitor 1 level in women. Int J Obes Relat Metab Disord 1998;22:312-7. (Pubitemid 28138436)
17. Cigolini M, Tonoli M, Borgato L, Frigotto L, Manzato F, et al. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? Atherosclerosis 1999;143:81-90. (Pubitemid 29138705)
18. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, et al. Production of plasminogen activator inhibitor 1 by human adipose tissue. Diabetes 1997;46:860-7.
19. Birgel M, Gottschling-Zeller H, Röhrig K, Hauner H. Role of cytokines in the regulation of plasminogen activator inhib-itor-1 expression and secretion in newly differentiated subcutaneous human adipocytes. Arterioscler Thromb Vasc Biol 2000;20:1682-7. (Pubitemid 30353905)
20. Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 1999;84:4097-105. (Pubitemid 30644201)
21. De Mitrio V, De Pergola G, Vettor R, Marino R, Sciaraffia M, et al. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. Metabolism 1999;48:960-4. (Pubitemid 29374911)
22. Söderberg S, Olsson T, Eliasson M, Johnson O, Ahrén B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 1999;245:533-43. (Pubitemid 29232244)
23. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, et al. CDC growth charts: United States. Advance data from vital and health statistics no. 314. Hyattsville, MD: National Center for Health Statistics, 2000.
24. National Health and Nutrition Examination Survey. Anthropometry procedures manual. Atlanta, GA: Centers for Disease Control and Prevention, 2000 (http://www.cdc.gov/nchs/data/nhanes/bm.pdf).
25. McCarthy HD, Jarrett KV, Crawley HF. The development of waist circumference percentiles in British children aged 5.0-16.9 years. Eur J Clin Nutr 2001;55:902-7. (Pubitemid 32927057)
26. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-44. (Pubitemid 39345977)
27. Roswall J, Bergman S, Almqvist-Tangen G, Alm B, Niklasson A, et al. Population-based waist circumference and waist-to-height ratio reference values in preschool children. Acta Paediatr 2009;98:1632-6.
28. Maffeis C, Banzato C, Talamini G. Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr 2008;152:207-13.
29. Garnett SP, Baur LA, Cowell CT. Waist-to-height ratio: a simple option for determining excess central adiposity in young people. Int J Obes 2008;32:1028-30. (Pubitemid 351986229)
30. Nambiar S, Truby H, Abbott RA, Davies PS. Validating the waist-height ratio and developing centiles for use amongst children and adolescents. Acta Paediatr 2009;98:148-52.
31. Benfield LL, Fox KR, Peters DM, Blake H, Rogers I, et al. Magnetic resonance imaging of abdominal adiposity in a large cohort of British children. Int J Obes 2008;32:91-9.
32. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(Suppl 2):555-76.
33. Tanner JM. Growth at adolescence, 2nd ed. Oxford: Blackwell Scientific, 1978:1440.
34. Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1998;71:220-5.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. (Pubitemid 15018832)
36. Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, et al. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2004;28:159-66. (Pubitemid 38142004)
37. Albisetti M, Chan AK, McCrindle BW, Wong D, Monagle P, et al. Impaired fibrinolytic activity is present in children with dys-lipidemias. Pediatr Res 2004;55:576-80. (Pubitemid 38405842)
38. Venugopal J, Hanashiro K, Nagamine Y. Regulation of PAI-1 gene expression during adipogenesis. J Cell Biochem 2007;101: 369-80. (Pubitemid 46698871)
39. Caron P, Bennet A, Camare R, Louvet JP, Boneu B, et al. Plasminogen activator inhibitor in plasma is related to testosterone in men. Metabolism 1989;38:1010-5. (Pubitemid 19255002)
40. Nordt TK, Sawa H, Fujii S, Sobel BE. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation 1995;91:764-70.
41. Smith CP, Archibald HR, Thomas JM, Tarn AC, Williams AJ, et al. Basal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol 1988;28:7-14. (Pubitemid 18027501)
42. Wabitsch M, Blum WF, Muche R, Braun M, Hube F, et al. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 1997; 100:808-13. (Pubitemid 27371698)
43. Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, et al. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients. Arterioscler Thromb Vasc Biol 2008;28:548-54.
44. Sarecka B, Zak I, Krauze J. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease. Clin Biochem 2008;41:467-73.
45. Kinik ST, Ataç FB, Verdi H, Cetintaş S, Sahin FI, et al. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children. Clin Endocrinol 2005;62:607-10. (Pubitemid 40646730)
46. Berberoǧlu M, Evliyaoǧlu O, Adiyaman P, Ocal G, Ulukol B, et al. Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children. J Pediatr Endocrinol Metab 2006; 19: 741-8.
47. Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, et al. Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits. J Thromb Haemost 2007;5: 313-20. (Pubitemid 46139456)
48. Schoenhard JA, Asselbergs FW, Poku KA, Stocki SA, Gordon S, et al. Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. Hum Genet 2008;124:479-88.
49. Misra M, Miller KK, Almazan C, Ramaswamy K, Aggarwal A, et al. Hormonal and body composition predictors of soluble lep-tin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 2004;89:3486-95. (Pubitemid 38951925)
50. Martos-Moreno GA, Barrios V, Argente J. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids. Eur J Endocrinol 2006;155:429-34. (Pubitemid 44463949)
51. Festa A, Williams K, Tracy RP, Wagenknecht LE, Haffner SM. Progression of plasminogen activator inhibitor-1 and fibrino-gen levels in relation to incident type 2 diabetes. Circulation 2006;113:1753-9. (Pubitemid 43958468)
52. Meigs JB, O'Donnell CJ, Tofler GH, Benjamin EJ, Fox CS, et al. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006;55:530-7. (Pubitemid 43343286)